Latest News Feed
QuesGen Systems, Inc., a provider of research services to organizations and investigators developing treatments for brain health and Traumatic Brain Injury (TBI), is expanding their business capabilities and is pleased to announce the formation of a business relationship with ImmunArray, a privately held molecular diagnostics company.
QuesGen Systems to attend FDA Workshop, "Advancing the Development of Biomarkers in Traumatic Brain Injury" in Silverspring MD, on March 3, 2016